Osteoporosis International

, Volume 22, Issue 1, pp 339–344

The hormonal profile of hip fracture female patients differs from community-dwelling peers over a 1-year follow-up period

  • A. R. Cappola
  • W. G. Hawkes
  • N. Blocher
  • J. Yu-Yahiro
  • D. Orwig
  • L. Fredman
  • R. R. Miller
  • J. M. Guralnik
  • J. Magaziner
Short Communication

DOI: 10.1007/s00198-010-1187-4

Cite this article as:
Cappola, A.R., Hawkes, W.G., Blocher, N. et al. Osteoporos Int (2011) 22: 339. doi:10.1007/s00198-010-1187-4
  • 80 Downloads

Abstract

Summary

Hormone levels were compared over a 1-year period between elderly women who had sustained a hip fracture and women of similar age and functional ability. Our study suggests progressive hormonal changes that may contribute to severe bone loss during the year following hip fracture.

Introduction

Alterations in hormones affecting the musculoskeletal system may increase risk of hip fracture or poor post-fracture recovery in postmenopausal women. Most studies lack appropriate reference groups, and thus cannot assess the extent to which these alterations are attributable to hip fracture.

Methods

Women aged ≥65 years hospitalized for an acute hip fracture (Baltimore Hip Studies, BHS-3; n = 162) were age-matched to 324 women enrolled in the Women’s Health and Aging Study I, a Baltimore-based cohort with similar functional status to the pre-fracture status of BHS-3 women. Both studies enrolled participants from 1992 to 1995. Insulin-like growth hormone-1 (IGF-1), parathyroid hormone (PTH), 1,25 dihydroxyvitamin D [1,25(OH)2D], and osteocalcin were evaluated at baseline and 2, 6, and 12 months post-fracture, and at baseline and 12 months in the comparison group. Between-group differences in trajectories of each hormone were examined.

Results

Baseline mean IGF-1 levels were significantly lower in hip fracture patients than the comparison group (75.0 vs. 110.5 μg/dL; p < 0.001). Levels increased by 2 months post-fracture, but remained significantly lower than those in the comparison group throughout the 12-month follow-up (p < 0.01). Levels of PTH and osteocalcin were similar between groups at baseline, but rose during the year post-fracture to significantly differ from the comparison women (p < 0.001). 1,25(OH)2D levels did not differ between the hip fracture and comparison women at any time.

Conclusions

Older women who have sustained a hip fracture have progressive changes in hormonal milieu that exceed those of women of similar health status during the year following fracture.

Keywords

1,25, Dihydroxyvitamin D Elderly Hip fracture Hormones IGF-1 Osteocalcin PTH Women 

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2010

Authors and Affiliations

  • A. R. Cappola
    • 1
  • W. G. Hawkes
    • 2
  • N. Blocher
    • 3
  • J. Yu-Yahiro
    • 4
  • D. Orwig
    • 2
  • L. Fredman
    • 5
  • R. R. Miller
    • 2
  • J. M. Guralnik
    • 6
  • J. Magaziner
    • 2
  1. 1.Division of Endocrinology, Diabetes and MetabolismUniversity of Pennsylvania School of MedicinePhiladelphiaUSA
  2. 2.Division of Gerontology, Department of Epidemiology and Preventive MedicineUniversity of MarylandBaltimoreUSA
  3. 3.Division of EndocrinologyAlbert Einstein Medical CenterPhiladelphiaUSA
  4. 4.Department of Orthopaedic SurgeryThe Union Memorial HospitalBaltimoreUSA
  5. 5.Department of EpidemiologyBoston University School of Public HealthBostonUSA
  6. 6.Laboratory of Epidemiology, Demography and BiometryNational Institute on AgingBethesdaUSA

Personalised recommendations